ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN, RABBIT
Myeloproliferative Neoplasm
Fred Hutchinson Cancer Centerother_biologicalPhase 2/3Active
BB
70/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 65/ 100
- Competitive Position
- 81/ 100
Competitive context
69 Active assets in the Myeloproliferative Neoplasm cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
MELPHALAN Center for International Blood and Marrow Transplant Research | Phase 2/3 | BBB |
Fludarabine Sawa Ito, MD | Phase 4 | BB |
Romidepsin Sawa Ito, MD | Phase 4 | BB |
FILGRASTIM City of Hope Medical Center | Phase 3 | BB |
ETOPOSIDE Memorial Sloan Kettering Cancer Center | Phase 3 | BB |
View all 50 →
Same molecule, other indications
ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN, RABBIT is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →